Fleebs-Logo
Details werden geladen...

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards | The Manila Times

ALISO VIEJO, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ('AEON” or the 'Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX® (onabotulinumtoxinA) for therapeutic use to achieve full-label U.S. market entry, today announced that it has received written notice from NYSE American LLC ('NYSE American”) confirming that AEON has regained compliance with NYSE American’s continued listing standards relating to stockholders’ equity.

Ähnliche Seiten

https://www.manilatimes.net/2026/06/27/tmt-newswire/globenewswire/matinas-biopharma-receives-notice-of-non-compliance-with-nyse-american-continued-listing-standards-and-acceptance-of-plan-to-regain-compliance/2374002

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance | The Manila Times

https://www.manilatimes.net/2026/06/27/tmt-newswire/globenewswire/matinas-biopharma-receives-notice-of-non-compliance-with-nyse-american-continued-listing-standards-and-acceptance-of-plan-to-regain-compliance/2374002
https://www.manilatimes.net/2026/06/30/tmt-newswire/pr-newswire/lightinthebox-regains-compliance-with-nyse-listing-requirements/2375821

LightInTheBox Regains Compliance with NYSE Listing Requirements | The Manila Times

https://www.manilatimes.net/2026/06/30/tmt-newswire/pr-newswire/lightinthebox-regains-compliance-with-nyse-listing-requirements/2375821
https://www.manilatimes.net/2026/06/15/tmt-newswire/globenewswire/aim-immunotech-regains-nyse-american-compliance-company-resolves-stockholder-equity-deficiency/2365545

AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency | The Manila Times

https://www.manilatimes.net/2026/06/15/tmt-newswire/globenewswire/aim-immunotech-regains-nyse-american-compliance-company-resolves-stockholder-equity-deficiency/2365545
https://www.manilatimes.net/2026/06/04/tmt-newswire/globenewswire/aeon-biopharma-to-present-data-demonstrating-structural-and-functional-comparability-of-abp-450-to-botox-at-the-68th-annual-scientific-meeting-of-the-american-headache-society/2358625

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society | The Manila Times

https://www.manilatimes.net/2026/06/04/tmt-newswire/globenewswire/aeon-biopharma-to-present-data-demonstrating-structural-and-functional-comparability-of-abp-450-to-botox-at-the-68th-annual-scientific-meeting-of-the-american-headache-society/2358625
https://www.finanznachrichten.de/nachrichten-2026-07/68955717-wallbox-n-v-wallbox-announces-nyse-acceptance-of-plan-to-regain-compliance-with-continued-listing-standards-004.htm

Wallbox N.V.: Wallbox Announces NYSE Acceptance of Plan to Regain Compliance with Continued Listing Standards

https://www.finanznachrichten.de/nachrichten-2026-07/68955717-wallbox-n-v-wallbox-announces-nyse-acceptance-of-plan-to-regain-compliance-with-continued-listing-standards-004.htm
https://www.manilatimes.net/2026/07/13/tmt-newswire/globenewswire/apollomics-regains-full-compliance-with-nasdaq-listing-requirements/2383315

Apollomics Regains Full Compliance with Nasdaq Listing Requirements | The Manila Times

https://www.manilatimes.net/2026/07/13/tmt-newswire/globenewswire/apollomics-regains-full-compliance-with-nasdaq-listing-requirements/2383315